I think this is the only one that touches on the subject http://www.ipharminc.com/press-release/2019/1/14/innovation-pharmaceuticals-completes-gastric-fluid-testing-of-brilacidin-supporting-development-of-an-oral-dosage-form-to-treat-inflammatory-bowel-disease